These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 25274536)

  • 21. Problems with oral formulations prescribed to children: a focus group study of healthcare professionals.
    Venables R; Stirling H; Batchelor H; Marriott J
    Int J Clin Pharm; 2015 Dec; 37(6):1057-67. PubMed ID: 26173937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient acceptability, safety and access: A balancing act for selecting age-appropriate oral dosage forms for paediatric and geriatric populations.
    Walsh J; Ranmal SR; Ernest TB; Liu F
    Int J Pharm; 2018 Feb; 536(2):547-562. PubMed ID: 28705619
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acceptability of Prednisolone in an Open-Label Randomised Cross-Over Study-Focus on Formulation in Children.
    Haslund-Krog SS; Jørgensen IM; Dalhoff K; Holst H
    Children (Basel); 2022 Aug; 9(8):. PubMed ID: 36010126
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acceptability of different oral dosage forms in paediatric patients in hospital setting.
    Pokharkar V; Sajith M; Vallet T; Akshantal S; Shah R; Ruiz F; Salunke S
    Arch Dis Child; 2022 Sep; 107(9):796-801. PubMed ID: 34799375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. European perspectives on pediatric formulations.
    Breitkreutz J
    Clin Ther; 2008 Nov; 30(11):2146-54. PubMed ID: 19108802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-human tools for the evaluation of bitter taste in the design and development of medicines: a systematic review.
    Mohamed-Ahmed AH; Soto J; Ernest T; Tuleu C
    Drug Discov Today; 2016 Jul; 21(7):1170-80. PubMed ID: 27240776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Co-Processed Excipients for Dispersible Tablets-Part 2: Patient Acceptability.
    Dziemidowicz K; Lopez FL; Bowles BJ; Edwards AJ; Ernest TB; Orlu M; Tuleu C
    AAPS PharmSciTech; 2018 Aug; 19(6):2646-2657. PubMed ID: 29943280
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of patient-reported outcome measurements as a reliable tool to measure acceptability of the taste of paediatric medicines in an inpatient paediatric population.
    Mistry P; Stirling H; Callens C; Hodson J; Batchelor H;
    BMJ Open; 2018 Jul; 8(7):e021961. PubMed ID: 29997143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. "I just take what I am given": adherence and resident involvement in decision making on medicines in nursing homes for older people: a qualitative survey.
    Hughes CM; Goldie R
    Drugs Aging; 2009; 26(6):505-17. PubMed ID: 19591525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can children swallow tablets? Outcome data from a feasibility study to assess the acceptability of different-sized placebo tablets in children (creating acceptable tablets (CAT)).
    Bracken L; McDonough E; Ashleigh S; Wilson F; Shakeshaft J; Ohia U; Mistry P; Jones H; Kanji N; Liu F; Peak M
    BMJ Open; 2020 Oct; 10(10):e036508. PubMed ID: 33039988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient acceptability of 3D printed medicines.
    Goyanes A; Scarpa M; Kamlow M; Gaisford S; Basit AW; Orlu M
    Int J Pharm; 2017 Sep; 530(1-2):71-78. PubMed ID: 28750894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Oral formulation of choice for children].
    Lajoinie A; Henin E; Kassai B
    Arch Pediatr; 2015 Aug; 22(8):877-85. PubMed ID: 26141805
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms.
    Lopez FL; Ernest TB; Tuleu C; Gul MO
    Expert Opin Drug Deliv; 2015; 12(11):1727-40. PubMed ID: 26165848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How can oral paediatric formulations be improved? A challenge for the XXI century.
    Moreira M; Sarraguça M
    Int J Pharm; 2020 Nov; 590():119905. PubMed ID: 32980507
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methods of administering oral formulations and child acceptability.
    van Riet-Nales DA; Ferreira JA; Schobben AF; de Neef BJ; Egberts TC; Rademaker CM
    Int J Pharm; 2015 Aug; 491(1-2):261-7. PubMed ID: 26143234
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects.
    van Riet-Nales DA; Schobben AF; Vromans H; Egberts TC; Rademaker CM
    Arch Dis Child; 2016 Jul; 101(7):662-9. PubMed ID: 26979250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taste masking technologies in oral pharmaceuticals: recent developments and approaches.
    Sohi H; Sultana Y; Khar RK
    Drug Dev Ind Pharm; 2004 May; 30(5):429-48. PubMed ID: 15244079
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapidly disintegrating risperidone in subjects with schizophrenia or schizoaffective disorder: a summary of ten phase I clinical trials assessing taste, tablet disintegration time, bioequivalence, and tolerability.
    Thyssen A; Remmerie B; D'Hoore P; Kushner S; Mannaert E
    Clin Ther; 2007 Feb; 29(2):290-304. PubMed ID: 17472821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acceptability of a Sublingual Drug Formulation for Respiratory Tract Infections in Children Aged 3 to 5 Years.
    Emeryk A; Vallet T; Wawryk-Gawda E; Jędrzejewski A; Durmont F; Ruiz F
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33672395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The application of tribology in assessing texture perception of oral liquid medicines.
    Batchelor H; Venables R; Marriott J; Mills T
    Int J Pharm; 2015 Feb; 479(2):277-81. PubMed ID: 25575471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.